These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2230235

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T, Heiligers JP, Tak CJ, Zijlstra FJ, Ben-Efraim S, Saxena PR, Bonta IL.
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Sun XM, Hsueh W.
    J Immunol; 1991 Jul 15; 147(2):509-14. PubMed ID: 2071893
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Acute portal hypertension increases ileal vulnerability to platelet-activating factor in rats.
    Sakaguchi T, Nakamura S, Suzuki S, Oda T, Ichiyama A, Baba S.
    J Surg Res; 1999 Sep 15; 86(1):116-22. PubMed ID: 10452877
    [Abstract] [Full Text] [Related]

  • 31. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
    Mozes T, Ben-Efraim S, Bonta IL.
    Pathol Biol (Paris); 1992 Oct 15; 40(8):807-12. PubMed ID: 1484741
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Two distinct signal transduction pathways for the activation of guinea-pig macrophages and neutrophils by endotoxin.
    Waga I, Nakamura M, Honda Z, Ferby I, Toyoshima S, Ishiguro S, Shimizu T.
    Biochem Biophys Res Commun; 1993 Dec 15; 197(2):465-72. PubMed ID: 8267581
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3).
    Shames R, Ruis NM, Valone FH.
    Int J Immunopharmacol; 1994 Apr 15; 16(4):335-43. PubMed ID: 8045673
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The production of experimental cholecystitis by endotoxin.
    Kaminski DL, Feinstein WK, Deshpande YG.
    Prostaglandins; 1994 Mar 15; 47(3):233-45. PubMed ID: 8016392
    [Abstract] [Full Text] [Related]

  • 39. Comparison of effects of platelet-activating factor and tumour necrosis factor-alpha on lipid metabolism in adrenalectomized rats in vivo.
    Evans RD, Williamson DH.
    Biochim Biophys Acta; 1991 Nov 05; 1086(2):191-6. PubMed ID: 1932101
    [Abstract] [Full Text] [Related]

  • 40. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F, Decker K.
    Eur Cytokine Netw; 1994 Nov 05; 5(3):311-7. PubMed ID: 7948767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.